Genelux - 53 Year Dividend History | GNLX
Historical dividend payout and yield for Genelux (GNLX) since 1971. The current TTM dividend payout for Genelux (GNLX) as of December 20, 2024 is $0.00. The current dividend yield for Genelux as of December 20, 2024 is 0.00%.
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.080B |
$0.000B |
|
Genelux Corporation is a clinical-stage biopharmaceutical company. It focused on developing a pipeline of next-generation oncolytic immunotherapies for patients suffering from aggressive and/or difficult-to-treat solid tumor types. The Company's most advanced product candidate, Olvi-Vec, is a proprietary, modified strain of the vaccinia virus, a stable DNA virus. Genelux Corporation is based in WESTLAKE VILLAGE, Calif.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
